Copyright
©The Author(s) 2025.
World J Psychiatry. Aug 19, 2025; 15(8): 106303
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.106303
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.106303
Table 2 Significant regression correlations between the Framingham risk score and all the factors in patients with depression
Characteristics | B (95%CI) | Beta | t | P value |
Illness duration | 0.02 (0.01-0.03) | 0.262 | 2.628 | 0.009 |
Medication duration | -0.02 (-0.04-0.00) | -0.189 | -1.875 | 0.063 |
Attack times | -0.43 (-1.26-0.40) | -0.088 | -1.029 | 0.305 |
Family history of psychosis | 2.29 (0.27-4.32) | 0.156 | 2.235 | 0.027 |
TSH | 0.23 (-0.27-0.74) | 0.062 | 0.904 | 0.367 |
Alb | 0.10 (-0.17-0.38) | 0.053 | 0.705 | 0.642 |
TBIL | 0.03 (-0.11-0.17) | 0.035 | 0.466 | 0.642 |
TG | 2.63 (1.69-3.56) | 0.415 | 5.560 | < 0.001 |
UA | 0.01 (0.00-0.02) | 0.155 | 2.105 | 0.037 |
- Citation: Zhou LN, Mao Y, Li BJ, Ma XC, Wang W. Novel biomarkers of the Framingham risk score in patients with depression: A cross-sectional study. World J Psychiatry 2025; 15(8): 106303
- URL: https://www.wjgnet.com/2220-3206/full/v15/i8/106303.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i8.106303